An FQ, Matsuda M, Fujii H, Tang RF, Amemiya H, Dai YM, Matsumoto Y (2001) Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin. Int J Cancer 93:468–474

Article  CAS  PubMed  Google Scholar 

Charrière B, Maulat C, Suc B, Muscari F (2016) Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol 8:881–890

Article  PubMed  PubMed Central  Google Scholar 

Delgado E, Bahal R, Yang J, Lee JM, Ly DH, Monga SP (2013) β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid. Curr Cancer Drug Targets 13:867–878

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evison BJ, Actis ML, Wu SZ, Shao Y, Heath RJ, Yang L, Fujii N (2014) A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA). Bioorg Med Chem 22:6333–6343

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gibbs PE, Miralem T, Maines MD (2015) Biliverdin reductase: a target for cancer therapy? Front Pharmacol 6:119

Article  PubMed  PubMed Central  Google Scholar 

Giles RH, van Es JH, Clevers H (2003) Caught up in a wnt Storm: wnt signaling in cancer. Biochim Biophys Acta 1653:1–24

CAS  PubMed  Google Scholar 

He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512

Article  CAS  PubMed  Google Scholar 

Juríková M, Danihel Ľ, Polák Š, Varga I (2016) Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of Breast cancer. Acta Histochem 118:544–552

Article  PubMed  Google Scholar 

Kaur P, Mani S, Cros MP, Scoazec JY, Chemin I, Hainaut P, Herceg Z (2012) Epigenetic silencing of sFRP1 activates the canonical wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumour Biol 33:325–336

Article  CAS  PubMed  Google Scholar 

Kubícková KN, Subhanová I, Konícková R, Matousová L, Urbánek P, Parobková H, Kupec M, Pudil J, Vítek L (2016) Predictive role BLVRA mRNA expression in hepatocellular cancer. Ann Hepatol 15:881–887

PubMed  Google Scholar 

Mailand N, Gibbs-Seymour I, Bekker-Jensen S (2013) Regulation of PCNA-protein interactions for genome stability. Nat Rev Mol Cell Biol 14:269–282

Article  CAS  PubMed  Google Scholar 

Mao H, Xu Y, Zhang Z, Sun G, Wang Z, Qiao D, Yin X, Liu S, Bo P (2020) Biliverdin reductase A (BLVRA) promotes colorectal cancer cell progression by activating the Wnt/β-catenin signaling pathway. Cancer Manag Res 12:2697–2709

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC (2004) High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of Hepatitis virus Infection, age, p53 and beta-catenin mutations. Int J Cancer 112:44–50

Article  CAS  PubMed  Google Scholar 

Rennoll S, Yochum G (2015) Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer. World J Biol Chem 6:290–300

Article  PubMed  PubMed Central  Google Scholar 

Shiani A, Narayanan S, Pena L, Friedman M (2017) The role of diagnosis and treatment of underlying liver disease for the prognosis of primary liver cancer. Cancer Control 24:1073274817729240

Article  PubMed  PubMed Central  Google Scholar 

Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, Ben-Ze’ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U.S.A. 96:5522–5527

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD (2019) Cancer statistics. CA Cancer J Clin 69:7–34

Article  PubMed  Google Scholar 

Susanti NMP, Tjahjono DH (2021) Cyclin-dependent kinase 4 and 6 inhibitors in cell cycle dysregulation for breast cancer treatment. Molecules 26:4462

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang B, Tang F, Wang Z, Qi G, Liang X, Li B, Yuan S, Liu J, Yu S, He S (2016) Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling. J Exp Clin Cancer Res 35:82

Article  PubMed  PubMed Central  Google Scholar 

Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426

Article  CAS  PubMed  Google Scholar 

Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339–346

Article  CAS  PubMed  Google Scholar 

Tran NL, Nagle RB, Cress AE, Heimark RL (1999) N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. Am J Pathol 155:787–798

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11:1487–1495

Article  CAS  PubMed  Google Scholar 

Yeung KT, Yang J (2017) Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol 11:28–39

Article  PubMed  Google Scholar 

Zhang X, Liu G, Kang Y, Dong Z, Qian Q, Ma X (2013) N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS One 8:e57692

Article  CAS  PubMed  PubMed Central  Google Scholar